UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
For the Quarterly Period Ended March 31, 2015
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 1-14106
DAVITA HEALTHCARE PARTNERS INC.
2000 16th Street
Denver, CO 80202
Telephone number (303) 405-2100
|
Delaware |
|
51-0354549 |
|
(State of incorporation) |
|
(I.R.S. Employer Identification No.) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No £
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No £
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
x |
Accelerated filer |
¨ |
|
|
|
|
|
|
Non-accelerated filer |
¨ (Do not check if a smaller reporting company) |
Smaller reporting company |
¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes £ No x
As of April 30, 2015, the number of shares of the Registrant’s common stock outstanding was approximately 215.0 million shares and the aggregate market value of the common stock outstanding held by non-affiliates based upon the closing price of these shares on the New York Stock Exchange was approximately $17.4 billion.
EXPLANATORY NOTE
DaVita HealthCare Partners Inc. is filing this Amendment No. 1 on Form 10-Q/A for the quarter ended March 31, 2015 (the “Form 10-Q”), which was originally filed with the Securities and Exchange Commission on May 5, 2015, for the sole purpose of furnishing corrected XBRL Interactive Data Files. Due to a filing error by a third party financial printer, the XBRL Interactive Data Files originally furnished with the Form 10-Q contained errors. No other changes have been made to the Form 10-Q.
Except as specifically described above, this Amendment No. 1 does not reflect events occurring after the filing of the Form 10-Q, does not update disclosures contained in the Form 10-Q and does not modify or amend the Form 10-Q.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
DAVITA HEALTHCARE PARTNERS INC. |
||
|
|
|
|
|
|
|
BY: |
|
/s/ JAMES K. HILGER |
|
|
|
|
James K. Hilger |
|
|
|
|
Interim Chief Financial Officer and Chief Accounting Officer* |
Date: May 8, 2015
|
* |
Mr. Hilger has signed both on behalf of the Registrant as a duly authorized officer and as the Registrant’s principal accounting officer. |
INDEX TO EXHIBITS
|
Exhibit |
|
|
|
Number |
|
|
|
|
|
|
|
12.1 |
|
Ratio of earnings to fixed charges. (2) |
|
|
|
|
|
20.1 |
|
Notice of Proposed Amended Settlement of Derivative Action, Final Settlement Hearing, and Right to Appear. (1) |
|
|
|
|
|
31.1 |
|
Certification of the Chief Executive Officer, dated May 8, 2015, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. P |
|
|
|
|
|
31.2 |
|
Certification of the Chief Financial Officer, dated May 8, 2015, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. P |
|
|
|
|
|
32.1 |
|
Certification of the Chief Executive Officer, dated May 8, 2015, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. P |
|
|
|
|
|
32.2 |
|
Certification of the Chief Financial Officer, dated May 8, 2015, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. P |
|
|
|
|
|
101.INS |
|
XBRL Instance Document. P |
|
|
|
|
|
101.SCH |
|
XBRL Taxonomy Extension Schema Document. P |
|
|
|
|
|
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document. P |
|
|
|
|
|
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document. P |
|
|
|
|
|
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document. P |
|
|
|
|
|
101.PRE |
|
XBRL Taxonomy Extension Presentation, Linkbase Document. P |
|
P |
Filed herewith. |
|
(1) |
Filed on January 22, 2015 as an exhibit to the Company’s Current Report on Form 8-K. |
|
(2) |
Filed on May 5, 2015 as an exhibit to the Company’s Quarterly Report on Form 10-Q. |